Large-scale testing (Phase 3)Ended earlyNCT03547154
What this trial is testing
Polyethylene Glycol Interferon Alfa-2b (PEG Intron) Versus Interferon Alfa-2b (INTRON^® A) in the Treatment of Newly Diagnosed Chronic Myelogenous Leukemia (CML) (C98026)
Who this might be right for
Chronic Myelogenous Leukemia
Merck Sharp & Dohme LLC 344